1-Aryl-4-substituted isoquinolines

Details for Australian Patent Application No. 2005243149 (hide)

Owner Neurogen Corporation

Inventors Lee, Kyungae; Maynard, George D.; Mitchell, Scott; Hutchison, Alan; Yuan, Jun

Agent Pizzeys

Pub. Number AU-A-2005243149

PCT Pub. Number WO2005/110991

Priority 60/569,182 08.05.04 US

Filing date 6 May 2005

Wipo publication date 24 November 2005

International Classifications

C07D 217/02 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/110991 Priority application(s): WO2005/110991

17 February 2011 Assignment before Grant

  Neurogen Corporation The application has been assigned to Novartis International Pharmaceutical Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005243153-Scalable synthesis of imidazole derivatives

2005243147-1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof